• Protease Inhibitor Cocktail EDTA-Free: Workflow Guide

  2026-08-19

  K1010 helps limit endogenous proteolysis during protein extraction and sample preparation with a broad-spectrum inhibitor mixture supplied as a 100X concentrate in DMSO. Its EDTA-free formulation is suited to phosphorylation-sensitive and divalent-cation-dependent workflows, but it should not be treated as a universal substitute for rapid cooling, validated lysis conditions, or assay-specific controls.

• nor-Binaltorphimine dihydrochloride: KOR Assays

  2026-08-19

  Explore how nor-Binaltorphimine dihydrochloride can convert circuit-level KOR biology into better-controlled opioid receptor antagonist assays. This article explains the laterality and duration findings of a 2023 Cell Reports study and translates them into practical decisions for pain modulation research.

• LY294002 in Reliable Cell Viability Assays

  2026-08-18

  Learn how LY294002 (SKU A8250) can improve the interpretation of PI3K-dependent viability, proliferation, apoptosis, and autophagy experiments. This scenario-based guide covers mechanism, dosing, solvent handling, assay controls, cross-domain interpretation, and practical product-selection criteria.

• Iptacopan (LNP023) in Complement Assays

  2026-08-18

  Learn how Iptacopan (LNP023), SKU C8699, can improve the interpretation of cell viability, proliferation, and cytotoxicity experiments involving complement activation. This scenario-based guide connects factor B inhibition with assay design, serum compatibility, dose selection, data interpretation, and practical product evaluation.

• Trelagliptin succinate: Chondrocyte Assays

  2026-08-17

  Trelagliptin succinate, also known as SYR-472 succinate, connects selective DPP-4 enzyme inhibition with practical workflows for glucose metabolism, inflammatory cartilage biology, and signaling studies. This guide translates the AMPK/SOX-9 chondrocyte evidence into dose selection, assay controls, troubleshooting, and translational experiment design.

• GRA12 and Cross-Strain Toxoplasma Virulence

  2026-08-17

  A recent preprint used pooled in vivo CRISPR-Cas9 screens across parasite strains and mouse backgrounds to identify GRA12 as a broadly required Toxoplasma gondii virulence factor. Follow-up experiments connect GRA12 loss to parasitophorous-vacuole collapse, host-cell necrosis, and a conserved protective function among related coccidian parasites.

• JXY, TLR4, and M1 Polarization in CAC

  2026-08-16

  Liu et al. show that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in mice while shifting macrophages toward an M1-like phenotype through TLR4-associated signaling. The study combines an orthotopic cancer model with macrophage assays, providing a preclinical framework for studying immune-microenvironment control of CAC rather than focusing only on tumor-cell growth.

• Anti Reverse Cap Analog for smRNA Workflows

  2026-08-15

  Anti Reverse Cap Analog helps researchers build directionally capped synthetic mRNAs for stronger translation initiation and more consistent protein expression. This guide connects ARCA-enabled in vitro transcription with a transgene-free hiPSC-to-oligodendrocyte workflow, while providing practical optimization and troubleshooting guidance.

• How In Vitro Assays Resolve Cancer Drug Responses

  2026-08-14

  Hannah Schwartz’s dissertation shows that relative viability and fractional viability are not interchangeable measures: one combines proliferative arrest with death, whereas the other more specifically reflects cell killing. This distinction provides a practical framework for interpreting anticancer experiments, including studies of growth-inhibitory agents such as Everolimus (RAD001).

• PPT: A Causal Probe for ERα in LUAD

  2026-08-14

  PPT (Propyl Pyrazole Triol) provides a selective way to test ERα function rather than relying on expression correlations alone. This article connects PPT assay design with FOXM1–ERα findings in female lung adenocarcinoma while defining practical controls, readouts, and limitations.

• Polyethylenimine Linear: PEI MW 40,000 Workflow

  2026-08-13

  Polyethylenimine Linear, PEI MW 40,000, supports serum-compatible DNA delivery from 96-well assays to bioreactor-scale transient expression. This guide translates the product’s endocytosis-based mechanism and a recent calcium-phosphate optimization study into practical setup, scaling, and troubleshooting decisions.

• Müller Cell PEDF Controls Retinal Neuron Survival

  2026-08-13

  Younis et al. identify a Müller cell–mediated pathway in which Ang-1 and Ang-2 oppositely regulate Tie-2/PI3K/Akt signaling, PEDF production, and retinal neuronal survival. The work shifts attention from direct neuronal angiopoietin responses toward glia-dependent neurovascular signaling and provides a mechanistic framework for studying hypoxic retinal injury.

• HyperScript™ Reverse Transcriptase for Complex RNA

  2026-08-12

  HyperScript™ Reverse Transcriptase is an engineered M-MLV Reverse Transcriptase for RNA to cDNA conversion from difficult templates. Its reduced RNase H activity, enhanced thermal stability, and reported cDNA capability up to 12.3 kb support cDNA synthesis for qPCR when RNA is scarce or structurally complex.

• Targeted mRNA Nanoparticles Repair the Poststroke BBB

  2026-08-12

  Gao and colleagues developed M2 microglia-targeting lipid nanoparticles that deliver interleukin-10 mRNA to ischemic brain lesions and reinforce an anti-inflammatory feedback loop. In mouse stroke models, this strategy reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and alleviated neurological deficits, while suggesting a therapeutic window extending to 72 hours after stroke.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody

  2026-08-11

  The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody is a Cy3-conjugated secondary antibody for detecting rabbit IgG in immunofluorescence assay, IHC, ICC, and flow cytometry workflows. Its affinity purification, H+L recognition, and defined storage formulation support sensitive fluorescence detection, but assay-specific validation remains necessary.

16227 records 1/1082 page Next 12345 下5页 Last page